Treatment Benefits Rheumatoid Arthritis

majority of subjects who failed on multiple DMARDs responded to combination methotrexate and infliximab therapy.

In the second set of findings, the investigators looked at whether patients' self-assessed outcomes for pain, disease activity (prevalence and severity of symptoms) and performance correlated with a rapid clinical improvement with combination therapy.